The FDA defines a biosimilars as biologic products approved because they're highly similar to existing medicines, but there's a lot more to understand. A biosimilar is a manufactured biologic ...

A recent review explored the benefits of biosimilars for patients with moderate to severe chronic plaque psoriasis.

With so many biosimilars in the U.S. pipeline, the federal government has had its hands full in recent months managing legislation and expectations from patient groups, health organizations, ...

Early next year, the chain will start producing a cheaper version of Humira, with other meds to follow. Here's what to know about biosimilar drugs. Jessica was a writer on the Wellness team, with a ...

Has the promise of biosimilars been fulfilled? Authors of a case study appearing in this month’s edition of Health Affairs call it “the best example to date” that biosimilars can successfully bring ...

Celltrion Inc., a leading South Korean biopharmaceutical company, said Friday its biosimilar for eye diseases has received approval for sale in the United States. The U.S. Food and Drug Administration ...

This is a developing news story. Please check back soon for updates. The FDA approved Eydenzelt, a biosimilar referencing ...

Omalizumab is indicated for the treatment of persistent asthma, chronic rhinosinusitis with nasal polyps, food allergies and ...

AbbVie is on the rebound after a sell-off on concerns about the pending FDA decision for a biosimilar drug. Humira and Enbrel are among the top-selling drugs to be copycatted but biosimilars are ...

Vascular endothelial growth factor (VEGF) inhibitor, Eydenzelt (aflibercept-boav), is now approved to treat retinal disease ...